Sorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: a complete response case according to modified RECIST criteria

Yuri CHO; Bo-Hyun KIM; Tae-Hyun KIM; Young-Hwan KOH; Joong-Won PARK.
Journal of Liver Cancer ; : 63-68, 2022.
Artículo en Inglés | WPRIM | ID: wpr-926064

Documentos relacionados

  1. Sorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: a complete response case according to modified RECIST criteria.
  2. [Leiomyosarcoma of the inferior vena cava: a case report].
  3. [Organ-invasive carcinoma of the pararenal gland involving the inferior vena cava: successful curative and interdisciplinary surgical management].
  4. [Leiomyosarcoma of the inferior vena cava: description of a new case and review of the literature].
  5. [Kidney cancer with invasion of the vena cava: classification, surgical strategy and results of treatment].
  6. Recurrent malignant peripheral nerve sheath tumor presenting as an asymptomatic intravenous thrombus extending to the heart: a case report.
  7. Efficacy of radiotherapy in combined treatment of hepatocellular carcinoma patients with portal vein tumor thrombus: a real-world study.
  8. Extramedullary intracardiac multiple myeloma misdiagnosed as a thrombus: a case report.
  9. Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
  10. Inferior vena cava tumor thrombus that directly infiltrated from paracaval lymph node metastases in a patient with recurrent hepatocellular carcinoma.